Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00292084
Status:
COMPLETED
Last Update Posted:
2008-01-21
First Post:
2006-02-13
Brief Title:
An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
Sponsor:
Organization:
BioWest Therapeutics Inc
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
60
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: